NCFBE Patients May Benefit from Apulmiq,Third Party Evaluation Shows - Bronchiectasis News Today
NCFBE Patients May Benefit from Apulmiq,Third Party Evaluation Shows Bronchiectasis News Today
Aradigm released details of an independent review of clinical trial results finding Apulmiq can delay flares in non-cystic fibrosis bronchiectasis patients.
Comments
Post a Comment